Welcome to LookChem.com Sign In|Join Free

CAS

  • or

861446-14-2

Post Buying Request

861446-14-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

861446-14-2 Usage

Uses

Different sources of media describe the Uses of 861446-14-2 differently. You can refer to the following data:
1. Resveratrol 3,4’Diacetate is a diacetylated derivative of Resveratrol (R150000), which inhibit platelet activating factor (PAF). Resveratrol 3,4’Diacetate is a naturally occurring compounds that dis plays antioxidant and antithrombotic activity.
2. Resveratrol 3,4’-Diacetate is a diacetylated derivative of Resveratrol (R150000), which inhibit platelet activating factor (PAF). Resveratrol 3,4’-Diacetate is a naturally occurring compounds that displays antioxidant and antithrombotic activity.

Check Digit Verification of cas no

The CAS Registry Mumber 861446-14-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,1,4,4 and 6 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 861446-14:
(8*8)+(7*6)+(6*1)+(5*4)+(4*4)+(3*6)+(2*1)+(1*4)=172
172 % 10 = 2
So 861446-14-2 is a valid CAS Registry Number.

861446-14-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name acetic acid,[4-[2-(3,5-dihydroxyphenyl)ethenyl]phenyl] acetate

1.2 Other means of identification

Product number -
Other names 1,3-Benzenediol,5-[(1E)-2-[4-(acetyloxy)phenyl]ethenyl]-,monoacetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:861446-14-2 SDS

861446-14-2Downstream Products

861446-14-2Relevant articles and documents

Immobilized Lipase Based on Hollow Mesoporous Silicon Spheres for Efficient Enzymatic Synthesis of Resveratrol Ester Derivatives

Xu, Liu-Jia,Yang, Tao,Wang, Jing,Huang, Feng-Hong,Zheng, Ming-Ming

, p. 9067 - 9075 (2021/03/01)

Enzymatic esterification of resveratrol is crucial for its potential application in lipophilic foods and drugs. However, the poor activity of the free enzyme hinders the reaction. In this work, the highly efficient enzymatic synthesis of resveratrol ester derivatives was achieved by immobilized lipase on hydrophobic modified hollow mesoporous silicon spheres (HMSS-C8). We preliminarily explored the use of Candida sp. 99-125 lipase (CSL) for the acylation of resveratrol, with a regioselectivity toward 3-OH- over 4'-OH-acylation. HMSS-C8 provided ideal accommodation for CSL with a loading capacity of up to 652 mg/g. The catalytic efficiency of CSL@HMSS-C8 was 15 times higher than that of free CSL, and the conversion of resveratrol reached 98.7% within only 2 h, which is the fastest value recorded in the current literature. After 10 cycles, the conversion remained up to 86.3%. Benefiting from better lipid solubility, the relative oxidation stability index values of oil containing monoester derivatives were 43.1%-68.8% and 23.9%-33.2% higher than that of refined oil and oil containing resveratrol, respectively. This research provides a new pathway for efficient enzymatic synthesis of resveratrol ester derivatives and demonstrates the potential application of resveratrol monoester derivatives as a group of excellent lipid-soluble antioxidants.

Synthesis of amphiphilic resveratrol lipoconjugates and evaluation of their anticancer activity towards neuroblastoma SH-SY5Y cell line

Chillemi, Rosa,Cardullo, Nunzio,Greco, Valentina,Malfa, Giuseppe,Tomasello, Barbara,Sciuto, Sebastiano

, p. 467 - 481 (2015/05/13)

Resveratrol, a polyphenol present in grapes and other edible plants, possesses several important pharmacological activities, including anticancer activity. Nevertheless, its therapeutic use is still limited because of some unfavourable physicochemical and pharmacokinetic properties, mainly, poor cellular uptake and too rapid metabolism resulting in elimination from the body. To meet these drawbacks, some resveratrol conjugates would be useful, which would possess improved stability, uptake and bioavailability than the lead compound, and the ability to release it once it is internalized into the cell. In this paper we report a synthetic strategy which allowed us to obtain new amphiphilic resveratrol derivatives starting from different selectively protected resveratrol phosphoramidites or even from the resveratrol triphosphoramidite. Specifically, resveratrol was conjugated through phosphate bridge(s) to different lipophilic groups related to membrane lipids, such as cholesteryl or diacylglycero moieties. All the new lipoconjugates were tested towards human neuroblastoma SH-SY5Y cells and proved to be significantly more active than resveratrol, with a concentration-dependent activity.

Practical preparation of resveratrol 3-O-β-D-glucuronide

Jungong, Christian S.,Novikov, Alexei V.

, p. 3589 - 3597,9 (2020/08/31)

A practical synthesis of resveratrol 3-Oβl-D-glucuronide, suitable for preparation of large quantities, was developed using selective deacetylation of resveratrol triacetate with ammonium acetate. A simplified procedure for large-scale preparation of resveratrol is also reported.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 861446-14-2